Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Cardiovascular Diseases
 More »

  • Improving Proteomics Approaches
    ... PARP activity has been implicated in several diseases, including cardiovascular, neurodegenerative diseases, and cancer. PARP repairs single-strand breaks that occur with ...
    5-15-2013
  • Mass Spec Provides Peek into PTMs
    ... which might provide a novel insight for the elucidation of the etiology and development of diabetes and the related diabetic cardiovascular diseases," Dr. Ma concludes. ...
    5-15-2013
  • Softening the Blow from FOLFOX Treatment
    ... Dr. Karlsson and colleagues carried out cardiovascular studies showing that mangafodipir ... PledPharma sees potential to use PLED-derivative compounds against several diseases, and ...
    5-15-2013
  • Biomarkers Take Center Stage
    ... and accelerating the development of novel therapies for treating inflammatory diseases. ... The Singulex Erenna System has also been applied to cardiovascular disease research, for ...
    5-1-2013
  • Comparative Genomics: Insights into Disease Susceptibility
    ... Rhesus macaques ( Macaca mulatta ) are proven models for the study of diseases such as HIV/AIDS, cardiovascular disease, obesity and diabetes, asthma, addiction, and age-related ...
    5-1-2013
  • Pfizer, Alberta Renew Funding for Translational Research
    remodeling; diabetes and cardiovascular or other chronic disease issues as they relate to the consequences of diabetes; and orphan and genetic diseases. "Alberta has a vibrant and ...
    4-25-2013
  • AstraZeneca, BIND Enter $200M+ Cancer Nanomedicine Agreement
    a $210 million deal it made with Pfizer to develop and commercialize Accurins, which have shown effectiveness against inflammatory diseases, cardiovascular diseases, and cancer. ...
    4-22-2013
  • Merck & Co. Opens Third Manufacturing Plant in China
    ... plant has a capacity of 16 high speed lines to package pharmaceutical tablets and sterile Merck medicines for diabetes, cardiovascular, infectious, respiratory and bone diseases. ...
    4-19-2013
  • Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs
    he called Merck's "significant presence in and commitment to the cardiovascular space." ... Xenon says it focuses on rare inherited human diseases representing severe and extreme ...
    4-17-2013
  • BMS, Santaris Make Potentially $100M+ mRNA-Targeting Deal
    both mRNA and microRNA, for a range of diseases including infectious and inflammatory ... medicines for the treatment of cardiovascular disease using the LNA drug platform. ...
    4-16-2013
  • Cytomics for Personalized Heart Health
    CytoVas' Vascular Profile Uses Biomarkers to Test Patients' Cardiovascular Status ... cytomics a valuable tool for studying diseases. "Cytomics offers an efficient ...
    4-15-2013
  • Yale Wins $10 Million Grant for Novel Immunobiology Research
    chronic illnesses, including cardiovascular disease, type 2 diabetes, autoimmune diseases, asthma and allergies, neurodegenerative diseases such as Alzheimer's disease, and cancer. ...
    4-9-2013
  • Pfizer, BIND Launch $210M+ Targeted Nanomedicine Collaboration
    permeability allow particles to escape the blood vessels, as well as against cardiovascular diseases, since the Accurins can bind to targets on blood vessels or plaque formations. ...
    4-2-2013
  • CDI, Coriell Win $26M Toward iPSC Lines, Biorepository
    disorders, liver diseases, cardiovascular diseases, neurodevelopmental disabilities such as cerebral palsy and infantile epilepsy, diseases of the eye, or respiratory diseases. ...
    4-1-2013
  • Reality Hinders Pharma's Big Plans in Emerging Markets
    increasingly shift toward "lifestyle" diseases more common in the U.S., Europe, and ... and antivirals (25%), cardiovascular (23%), and central nervous system (16%). ...
    4-1-2013
  • More »

    Journal Articles

  • Prevalence of Metabolic Syndrome in Pakistan
    Abdul Basit, A. Samad Shera
    Metabolic Syndrome and Related Disorders
    for metabolic syndrome are to reduce the risks of cardiovascular disease and diabetes. ... and nationwide surveillance and prevention programs against noncommunicable diseases.
  • The Survey on Cellular and Engineered Tissue Therapies in Europe...
    Chiara Bocelli-Tyndall, Ineke Slaper-Cortenbach, Jakob Passweg, Alan Tyndall, Ivan Martin, Helen Baldomero
    Tissue Engineering, Part A
    (9%; 84% autologous), or neurological diseases (3%; 50% autologous). Autologous cells were used predominantly for cardiovascular (42%) and musculoskeletal (30%) disorders, ...
  • Statins Could Be Used to Control Replication of Some Viruses...
    Caroline Gilbert, Marc Bergeron, Sylvie Méthot, Jean-François Giguère, Michel J. Tremblay
    Viral Immunology
    Statins are mainly known for their plasma cholesterol-lowering properties and are widely used for the prevention of cardiovascular diseases. They however also exert pleiotropic ...
  • Seasonal and Weekly Patterns of Occurrence of Acute Cardiovascular...
    Roberto Manfredini, Fabio Fabbian, Marco Pala, Ruana Tiseo, Alfredo De Giorgi, Fabio Manfredini, Anna Maria Malagoni, Fulvia Signani, Candida Andreati, Benedetta Boari, Raffaella Salmi, Davide Imberti, Massimo Gallerani
    Journal of Women's Health
    Seasonal and Weekly Patterns of Occurrence of Acute Cardiovascular Diseases: Does a Gender Difference Exist? Journal of Women's Health Abstract Background: Cardiovascular (CV) ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll